In the last trading session, 3.48 million Aspire Biopharma Holdings Inc (NASDAQ:ASBP) shares changed hands as the company’s beta touched 0.82. With the company’s per share price at $0.28 changed hands at -$0.03 or -7.03% during last session, the market valuation stood at $14.09M. ASBP’s last price was a discount, traded about -5542.86% off its 52-week high of $15.80. The share price had its 52-week low at $0.22, which suggests the last value was 21.43% up since then. When we look at Aspire Biopharma Holdings Inc’s average trading volume, we note the 10-day average is 6.37 million shares, with the 3-month average coming to 13.21 million.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information
Instantly ASBP was in red as seen at the end of in last trading. With action -1.90%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -97.38%, with the 5-day performance at -1.90% in the red. However, in the 30-day time frame, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) is -59.73% down. Looking at the short shares, we see there were 0.67 million shares sold at short interest cover period of 0.02 days.
ASBP Dividends
Aspire Biopharma Holdings Inc is expected to release its next quarterly earnings report in July.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 33.08% of Aspire Biopharma Holdings Inc shares while 2.90% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.34%.
